PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR.

Jiang Y, Lim J, Wu KC, Xu W, Suen JY, Fairlie DP
Br J Pharmacol. 2021 Feb;178(4):913-932. doi: 10.1111/bph.15332. Epub 2020 Dec 30. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.